Heart Test Laboratories, Inc. (NASDAQ:HSCS – Free Report) – Research analysts at Ascendiant Capital Markets raised their Q4 2025 earnings estimates for Heart Test Laboratories in a research note issued to investors on Tuesday, March 18th. Ascendiant Capital Markets analyst L. Ward now forecasts that the company will post earnings per share of ($2.51) for the quarter, up from their prior forecast of ($2.57). Ascendiant Capital Markets has a “Buy” rating and a $14.00 price objective on the stock. The consensus estimate for Heart Test Laboratories’ current full-year earnings is ($10.01) per share. Ascendiant Capital Markets also issued estimates for Heart Test Laboratories’ Q1 2026 earnings at ($2.41) EPS, Q2 2026 earnings at ($2.46) EPS, Q3 2026 earnings at ($2.49) EPS, Q4 2026 earnings at ($2.42) EPS and FY2026 earnings at ($9.78) EPS.
Separately, Maxim Group reissued a “buy” rating and set a $12.00 price objective on shares of Heart Test Laboratories in a report on Wednesday, December 18th.
Heart Test Laboratories Price Performance
Heart Test Laboratories stock opened at $2.91 on Friday. The firm has a market capitalization of $2.85 million, a P/E ratio of -0.37 and a beta of 2.77. Heart Test Laboratories has a one year low of $2.36 and a one year high of $13.50. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.72 and a quick ratio of 1.52. The business has a fifty day moving average price of $3.39 and a 200-day moving average price of $3.42.
Heart Test Laboratories (NASDAQ:HSCS – Get Free Report) last released its quarterly earnings data on Thursday, March 13th. The company reported ($2.57) EPS for the quarter, missing the consensus estimate of ($2.53) by ($0.04).
About Heart Test Laboratories
Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.
Featured Stories
- Five stocks we like better than Heart Test Laboratories
- What is a Death Cross in Stocks?
- FedEx Delivers Another Crushing Blow to Its Stock Price
- What is a Secondary Public Offering? What Investors Need to Know
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- How to Invest in Blue Chip Stocks
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
